Crossmark

The evolution of heart failure with reduced ejection fraction pharmacotherapy: What do we have and where are we going?

Crossref DOI link: https://doi.org/10.1016/j.pharmthera.2017.03.011

Published Print: 2017-10

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Selim, Ahmed

Zolty, Ronald

Chatzizisis, Yiannis S.
License Information

Text and Data Mining valid from 2017-10-01
More Information

This article is maintained by: Elsevier

Article Title: The evolution of heart failure with reduced ejection fraction pharmacotherapy: What do we have and where are we going?

Journal Title: Pharmacology & Therapeutics

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.pharmthera.2017.03.011

Content Type: article

Copyright: © 2017 Elsevier Inc. All rights reserved.